Lafti L10 caps
Natural health product licensed in Canada
- Other names
- Lactobacillus LAFTI L10 capsules
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80064384
- Status
- Active licence
- Licence date
- 1 October 2015
- Revision date
- 4 June 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus helveticus Source : En entier | 5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Saccharose, Acide ascorbique, Maltodextrine, Stéarate de magnésium, Extrait de Levure, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of probiotics. Promotes gastrointestinal health in physically active adults. Helps reduce the incidence of cold-like symptoms in adults with exercise-induced stress. With 20 billion CFU per day, this product: Source of antioxidant probiotic Source of antioxidant probiotic in elite athletes
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. dirrhea) occurs and/or persists beyond 3 days, discontinue use and consult a health care practitioner. This product has been into contact with soy. If you have a soy allergy, do not use this product.
Source
Official Health Canada record, licence 80064384
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging